UvA-DARE is a service provided by the library of the University of Amsterdam (http://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

FcgammaRIIIb shedding from human neutrophils

Middelhoven, P.J.

Link to publication

Citation for published version (APA):Middelhoven, P. J. (1999). FcgammaRIIIb shedding from human neutrophils.

General rightsIt is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s),other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons).

Disclaimer/Complaints regulationsIf you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, statingyour reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Askthe Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam,The Netherlands. You will be contacted as soon as possible.

Download date: 10 Aug 2020

References

REFERENCES

Allen, J.M., and Seed, B. (1989). Isolation and expression of functional high-affinity Fc receptor complementary DNAs. Science 243:378-381.

Allport, J.R., Ding, H.T., Ager, A., Steeber, D.A., Tedder, T.F., and Luscinskas, F.W. (1997). L-selectin shedding does not regulate human neutrophil attachment, rolling, or transmigration across human vascular endothelium in vitro. J. Immunol. 158:4365^-372.

Almeida, E.A.C., Huovilla, A.-P.J., Sutherland, A.E., Stephens, L.E., Calarco, P.G., Shaw, L.M., Mercurio, A.M., Sonnenberg, A., Primakoff, P., Myles, D.G., and White, J.M. (1995). Mouse egg integrin a6ß, functions as a sperm receptor. Cell 81:1095-1104.

Anderson, C.L., and Looney, R.J. (1986). Human leukocyte IgG Fc receptors. Immunol. Today 7:264-266.

Arribas, J., Coodly, L., Vollmer, P., Kishimoto, T.K., Rose-John, S., and Massagué, J. (1996). Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J. Biol. Chem. 271:11376-11382.

Arribas, J., López-Casillas, F., and Massaqué, J. (1997). Role of the juxtamembrane domains of the transforming growth factor-a precursor and the ß-amyloid precursor protein in regulated ectodomain shedding. J. Biol. Chem. 272:17160-17165.

Asagoe, K., Yamamoto, K., Takahashi, A., Suzuki, K., Maeda, A., Nohgawa, M., Harakawa, N., Takano, K., Mukaida, N., Matsushima, K., Okuma, M., and Sasada, M. (1998). Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-a. J. Immunol. 160:4518-4525.

Astier, A., de la Salle, H., de la Salle C , Bieber, T., Esposito-Farese, M.-E., Freund, M., Cazenave, J.-P., Fridman, W.-H., Teillaud, J.-L., and Hanau, D. (1994). Human epidermal Langerhans cells secrete a soluble receptor for IgG (FcyRII/CD32) that inhibits the binding of immune complexes to FcyR+ cells. J. Immunol. 152:201-212.

Astier, A., de la Salle, H., Moncuit, J., Freund, M., Cazenave, J.-P., Fridman, W.-H., Hanau, D., and Teillaud, J.-L. (1993). Detection and quantification of secreted soluble FcyRIIA in human sera by an enzyme-linked immunosorbent assay. J. Immunol. Methods 166:1-10.

Bazil V., and Strominger, J.L. (1994). Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD 16 from stimulated human granulocytes. Induction of cleavage of L-Selectin via CD 16. J. Immunol. 142:1314-1322.

Beckett, R.P., Davidson, A.H., Drummond, A.H., Huxley, P., and Whittaker, M. (1996). Recent advances in matrix metalloproteinase inhibitor research. Drug Discovery Today 1:16-26.

Bennett, T.A., Lynam, E.B., Sklar, L.A., and Rogelj, S. (1996). Hydroxymate-based metalloprotease inhibitor blocks shedding of L-selectin adhesion molecule from leukocytes. Functional consequences for neutrophil aggregation. J. Immunol. 156:3093-3097.

Bergmeyer, H.A. (1970) in Methoden der Enzymatischen Analyse, pp. 1173, Band II, Verlag-Chemie, Weinheim.

Björnberg, F., and Lantz, M. (1998). Adherence to endothelial cells induce release of soluble tumor necrosis factor (TNF) receptor forms from neutrophil granulocytes. Biochem. Biophys. Res. Commun. 244:594-598.

87

References

Black, R.A., Dune, F.H., Otten-Evans, C , Miller, R., Slack, J.L., Lynch, D.H., Castner, B., Monier, K.M., Gerhart, M., Johnson, R.S., Itoh, Y., Okada.Y., and Nagase, H. (1996). Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-a (TNF-a) production suggest the major TNF-a converting enzyme is not an MMP. Biochem. Biophys. Res. Commun. 225:400^105.

Black, R.A., Rauch, CT. , Kozlosky, C.J., Peschon, J.J., Slack, J.L., Wolfson, M.F., Castner, B.J., Stocking, K.L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K.A., Gerhart, M., Davis, R., Fitzner, J.N., Johnson, R.S., Paxton, R.J., March, C.J., and Cerretti, D.P. (1997). A metalloproteinase disintegrin that releases tumour-necrosis factor-a from cells. Nature 385:729-733.

Black, R.A., and White, J.M. (1998). ADAMs: focus on the protease domain. Curr. Opin. Cell. Biol. 10:654-659.

Borregaard, N., Kjeldsen, L., Sengelov, H., Diamond, M.S., Springer, T.A., Anderson, H.C., Kishimoto, T.K., and Bainton, D.F. (1994). Changes in subcellular localization and surface expression of L-selectin, alkaline phosphatase, and Mac-1 in human neutrophils during stimulation with inflammatory mediators. J. Leukoc. Biol. 56:80-87.

Borregaard N., and Cowland, J.B. (1997). Granules of the human neutrophilic polymorpho-nuclear leukocyte. Blood 89:3503-3521.

Botto, M., Theodoridis, E., Thompson, E.M., Beynon, H.L.C., Briggs, D., Isenberg, D.A., Walport, M.J., and Davies, K.A. (1996). FcyRIIa polymorphism is Systemic Lupus Erythematosis (SLE): no association with disease. Clin. Exp. Immunol. 104:264-268.

Bottomley, K.M., Borkakoti, N., Bradshaw, D., Brown, P.A., Broadhurst, M.J., Budd, J.M., Elliott, L., Eyers, P., Hallam., T.J., Handa, B.K., Hill, C.H., James, M., Lahm, H.W., Lawton, G., Merritt, J.E., Nixon, J.S., Röthlisberger, U., Whittle, A., and Johnson, W.H. (1997). Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors. Biochem. J. 323:483-488 (compound xiii is Ro32-1541).

Bottomley, K.M., Johnson, W.H., and Walter, D.S. (1998). Matrix metalloproteinase inhibitors in Arthritis. J. Enzym Inhib. 13:79-101 (compound 15 is Ro32-0526 and compound 25 is Ro32-3580).

Bouchard, C , Galinha, A., Tartour, E., Fridman, W.-H., and Sautés, C. (1995). A transforming growth factor ß-like immunosuppressive factor in immunoglobulin G-binding factor. J. Exp. Med. 182:1717-1726.

Brakebusch, C , Varfolomeev, E.E., Batkin, M., and Wallach, D. (1994). Structural requirements for inducible shedding of the p55 tumor necrosis factor receptor. J. Biol. Chem. 269:32488-32496.

Brandt, J.T., Isenhart, CE., Osborne, J.M., Ahmed, A., and Anderson, CL. (1995). On the role of platelet FcyRIIa phenotype in Heparin-Induced Thrombocytopenia. Thromb. Haemost. 74:1564-1572.

Bredius, R.G.M., Fijen, C.A.P., de Haas, M., Kuijper, E.J., Weening, R.S., van de Winkel, J.G.J., and Out, T.A. (1994). Role of neutrophil FcyRIIa (CD32) and FcyRIIIb (CD 16) polymorphic forms in phagocytosis of human IgGr and IgG3-opsonized bacteria and erythrocytes. Immunology 83:624-630.

Brooks, D.G., Qiu, W.Q., Luster, A.D., and Ravetch, J.V. (1989). Structure and expression of human IgG FcRII (CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J. Exp. Med. 170:1369-1385.

Bubb, M.R., Senderowicz, A.M.J., Sausville, E.A., Duncan, K.L.K., and Korn, E.D. (1994). Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin. J. Biol. Chem. 269:14869-14871.

Bux, J., Stein, E.-L., Bierling, P., Fromont, P., Clay, M., Stroncek, D., and Santoso, S. (1997). Characterization of a new alloantigen (SH) on the human neutrophil Fey Receptor Illb. Blood 89:1027-1034.

88

References

Buxbaum, J.D., Liu, K.N., Luo, Y., Slack, J.L., Stocking, K.L., Peschon, J.J., Johnson, R.S., Castner, B.J., Cerretti, D.P., and Black, R.A. (1998). Evidence that tumor necrosis factor a converting enzyme is involved in regulated a-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273:27''65-27''67'.

Campanero, M.R., Pulido, R, Alosno, J.L., Pivel, J.P., Pimentel-Muifios, Fresno, M., and Sânchez-Madrid, F. (1991). Down-regulation by tumor necrosis factor-cc of neutrophil cell surface expression of the sialophonn CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism. Eur. J. Immunol. 21:3045-3048.

Carr, R., Huizinga, T.W.J., Kleijer, M., and Davies, J.M. (1992). Changes in plasma FcRHI demonstrate increasing receptor production during late pregnancy. Pediatr. Res. 32:505-508.

Ceuppens, J.L., Baroja, MX., van Vaeck, F., and Anderson, C.L. (1988). Defect in the membrane expression of high affinity 72-kD Fc y receptors on phagocytic cells in four healthy subjects. J. Clin. Invest. 82:571-578.

Clark, M.R., Liu, L., Clarkson, S.B., Ory, P.A., and Goldstein, I.M. (1990). An abnormality of the gene that encodes neutrophil Fc Receptor III in a patient with Sytemic Lupus Erythematosus. J. Clin. Invest. 86:341-346.

Colotta F , Orlando, S„ Fadlon, E.J., Sozzani, S., Matteucci, C, and Mantovani, A. (1995). Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells. J. Exp. Med. 181:2181-2188.

Crews, P., Manes, L.V., and Boehler, M. (1986). Jasplakinolide, a cyclodepsipeptide from the marine sponge, jaspis sp. Tetrahydron Lett. 27:2797-2800.

Daëron, M., Latour, S., Malbec, O., Espinosa, E., Pina, P., Pasmans, S., and Fridman, W.H. (1995). The same tyrosinê-based inhibition motif, in the intracytoplasmic domain of FcyRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 3:635-646.

Daëron, M. (1997). Fc receptor biology. Annu. Rev. Immunol. 15:203-234.

Detmers, P.A., Zhou, D., Powell, D., Lichenstein, H., Kelley, M„ Pironkova, R. (1995). Endotoxin receptors (CD 14) are found with CD 16 (FcyRIII) in an intracellular compartment of neutrophils that contains alkaline phosphatase. J. Immunol. 155:2085-2095.

Dong, Z.M., and Murphy, J.W. (1996). Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. J. Clin. Invest. 97:689-698.

Downey, G.P., Kin Chan, C , Lea, P., Takai, A., and Grinstein, S. (1992). Phorbol ester-induced actin assembly in neutrophils: role of protein kinase C. J. Cell Biol. 116:695-706.

Dransfield, I„ Buckle, A.M., Savill, J.S., McDowall, A„ Haslett, C , and Hogg, N. (1994). Neutrophil apoptosis is associated with a reduction in CD16 (FcyRIII) expression. J. Immunol. 153:1254-1263.

Duits A J Bootsma, H„ Derksen, R.H.W.M., Spronk, P.E., Kater, L., Kallenberg, C.G.M., Capel, P.J.A., WesterdaaL, N.A.C., Spierenburg, G.T., Gmelig-Meyling, F.H.J., and van de Winkel, J.G.J. (1995). Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in Systemic Lupus Erythematosus patients. Arthritis Rheum. 39:1832-1836.

Edberg, J.C., Salmon, J.E., and Kimberly, R.P. (1992). Functional capacity of Fey receptor III (CD16) on human neutrophils. Immunol. Res. 11:239-251.

Edberg, J.C., and Kimberly, R.P. (1994). Modulation of Fey and complement receptor function by the glycosyl-phosphatidylinositol-anchored from of FcyRIII. J. Immunol. 156:5826-5835.

Ehlers, M.R.W., Schwager, S.L.U., Scholle, RR., Manji, GA., Brandt, W.F., and Riordan, J.F. (1996). Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence. Biochemistry 35:9549-9559.

89

References

Ernst, L.K., van de Winkel, J.G.J., Chiu, LM., and Anderson, CL. (1992). Three genes for the human high affinity Fc receptor for IgG (FcyRJ) encode four distinct transcription products. J. Biol. Chem. 267:15692-15700.

Favoreel, H.W., Nauwynck, H.J., van Oostveldt, P., Mettenleiter, T.C., and Pensaert, M.B. (1997). Antibody-dependent and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on Pseudorabies virus-infected cells. J. Virol. 71:8254-8261.

Feehan, C , Darlak, K., Kahn, J., Walcheck, B., Spatola, A.F., and Kishimoto, T.K. (1996). Shedding of the lymphocyte L-selectin adhesion molecule is inhited by a hydroxamic acid-based protease inhibitor. Identification with an L-selectin-alkaline phosphatase reporter. J. Biol. Chem. 271:7019-7024.

Ferrante, A., Beard, L.J., and Feldman, R.G. (1990). IgG subclass distribution of antibodies to bacterial and viral antigens. Pediatr. Infect. Dis. J. 9:S16-S24.

Fleit, H.B., Kobasiuk, CD., Daly, C , Furie, R., Levy, P.C., and Webster, R.O. (1992). A soluble form of FcyRIII is present in human serum and other body fluids and is elevated at sites of inflammation Blood 792721-2728.

Fleit, H.B., and Kobasiuk, CD. (1993). Soluble FcyRIII is present in lower concentrations in the serum of patients with Acute Myelogenous Leukemia (AML): a retrospective study. Leukemia 7:1250-1252.

Fridman, W.-H., Teillaud, J.-L., Bouchard, C, Teillaud, C, Astier, A., Tartour, E., Galon, J., Mathiot, C, and Sautés, C. (1993). Soluble Fey receptors. J. Leukoc. Biol. 54:504-512.

Fromont, P., Bettaieb, A., Skouri, H., Floch, C, Poulet, E., Duedari, N., and Bierling, P. (1992). Frequency of the polymorphonuclear neutrophil Fey receptor III deficiency in the French population an its involvement in the development of neonatal alloimmune neutropenia. Blood 79:2131-2134.

Gachet, C , Astier, A., de la Salle, H., de la Salle, C, Fridman, W.-H., Cazenave, J.-P., Hanau, D., and Teillaud, J.-L. (1995). Release of FcyRIIa2 by activated platelets and inhibition of anti-CD9-mediated platelet aggregation by recombinant FcyRIIa2. Blood 85:698-704.

Galon J., Gauchat, J.-F., Mazières, N , Spagnoli, R., Storkus, W., Lötze, M., Bonnefoy, J.-Y., Fridman, W.-H., and Sautés, C. (1996). Soluble Fey Receptor type III (FcyRIII, CD 16) triggers cell activation through interaction with complement receptors. J. Immunol. 157:1184-1192.

Galon, J., Paulet, P., Galinha, A., Lores, P., Bonnerot, C, Jami, J., Fridman, W.-H., and Sautés, C. (1997). Soluble Fey receptors: interaction with ligands and biological consequences. Intern. Rev. Immunol. 16:87-111.

Galon, J., Moldovan, I., Galinha, A., Provost-Marloie M.A., Kaudewitz, H, Roman-Roman, S., Fridman, W.-H., and Sautés, C. (1998). Identification of the cleavage site involved in production of plasma soluble Fc'gamma receptor type III (CD16). Eur. J. Immunol. 28:2101-2107.

Gamble, J.R., Harlan, J.M., Klebanoff, S.J., Vadas, MA. (1985). Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sei. USA 82:8667-8671.

Ghirlando, R., Keown, M.B., MacKay, G.A., Lewis, M.S., Unkeless, J.C, and Gould, H.J. (1995). Stoichiometry and thermodynamics of the interaction between the Fc fragment of human IgG, and its low-affinity receptor FcyRIII. Biochemistry 34:13320-13327.

Gullberg, U., Lantz, M., Lindvall, L„ Olsson, I., and Himmler, A. (1992). Involvement of an Asn/Val cleavage site in the production of a soluble form of human tumor necrosis factor (TNF) receptor. Site-directed mutagenesis of a putative cleavage site in the p55 TNF receptor chain. Eur. J. Immunol. 58:307-312.

de Haas, M., Kleijer, M„ Minchinton, R.M., Roos, D„ and von dem Borne, A.E.G.Kr. (1994a). Soluble FcyRIIIIa is present in plasma and is derived from natural killer cells. J. Immunol 52900-907 90

References

de Haas, M., Kerst, J.M., van der Schoot, CE. , Calafat, J., Hack, CE. , Nuijens, J.H., Roos, D., van Oers, R.H.J. and von dem Borne, A.E.G.Kr. (1994b) Granulocyte Colony-Stimulating Factor administration to healthy volunteers: analysis of the immediate activationg effects of circulating neutrophils. Blood 84:3885-3894.

de Haas, M., Kleijer, M., van Zwieten, R., Roos, D., and von dem Borne, A.E.G.Kr. (1995). Neutrophil FcyRIIIb deficiency, nature and clinical consequences: a study of 21 individuals from 14 families. Blood 86:2403-2413.

de Haas, M., Koene, H.R., Kleijer, M., de Vries, E., Simsek, S., van Tool, M.J.D., Roos, D., and von dem Borne, A.E.G.Kr. (1996). A triallelic Fey receptor type IIIA polymorphism influences the binding of human IgG to NK cell FcyRIIIa. J. Immunol 156:2948-2955.

Harrison, D., Philips, J.H., and Lanier, L.L. (1991). Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated FcyRIII (CD16-II). / . Immunol. 147:3459-3465.

Hartneil, A., Kay, A.B., and Wardlaw, A.J. (1992). IFN-y induces expression of FcyRIII (CD16) on human eosinophils./. Immunol. 148:1471-1478.

Hazenbos, W.L.W., Gessner, J.E., Hofhuis, F.M.A., Kuipers H., Meyer, D., Heijnen I.A.F.M., Schmidt, R.E., Sandor, M., Capel P.J.A., Daëron, M., van de Winkel, J.G.J., and Verbeek, J.S. (1996). Impaired IgG-dependent anaphylaxis and Arthus reaction in FcyRIII (CD16) deficient mice. Immunity 5:181-188.

Hazenbos, W.L.W., Heijnen, I.A.F.M., Meyer, D., Hofhuis, F.M.A., Renardel de Lavalette, C , Schmidt, R.E., Capel, P.J.A., van de Winkel, J.G.J., Gessner, JE., van den Berg, T.K., and Verbeek, J.S. (1998). Murine IgG, complexes trigger immune effector functions predominantly via FcyRIII (CD16). J. Immunol. 161:3026-3032.

van den Herik-Oudijk, I.E., Westerdaal, N.A.C., Henriquez, N.V., Capel, P.J.A., and van de Winkel, J.G.J. (1994). Functional anaylis of human FcyRII (CD32) isoforms expressed in B Lymphocytes. J. Immunol. 152:574-585.

Homburg, C.H.E., de Haas, M., von dem Borne, A.E.G.Kr., Verhoeven, A.J., Reutelingsperger, C.P.M., and Roos, D. (1995). Human neutrophils lose their surface FcyRIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 85:532-540.

Hooper, N.M., Karran, E.H., and Turner, A.J. (1997). Membrane protein secretases. Biochem. J. 321:265-279.

Hooper, N.M. (1998). Membrane biology: do glycolipid microdomains really exist? Curr. Biol. 8:R114-R116.

Hoover, R.G., Lary, C, Page, R., Travis, P., Owens, R., Flick, J., Kornbluth, J., and Barlogie, B. (1995). Autoregulatory circuits in myeloma. Tumor cell cytotoxicity mediated by soluble CD16. J. Clin. Invest. 95:241-247.

Huizinga, T.W.J., van der Schoot, CE., Jost, C , Klaassen, R., Kleijer, M., von dem Borne, A.E.G.Kr., Roos, D., and Tetteroo, P A T . (1988). The Pi-linked receptor FcRIII is released on stimulation of neutrophils. Nature 333:667-669.

Huizinga, T.W.J., Kerst, M., Nuyens, J.H., Vlug, A., von dem Borne, A.E.G.Kr., Roos, D., and Tetteroo, P.A.T. (1989). Binding characteristics of dimeric IgG subclass complexes to human neutrophils. J. Immunol. 142: 2359-2364.

Huizinga, T.W.J., Kleijer, M., Tetteroo, P.A.T., Roos, D., and von dem Borne, A.E.G.Kr. (1990a). Biallelic neutrophil NA-antigen system is associated with a polymorphism on the phospho-inositol-linked Fey receptor III (CD 16). Blood 75:2l3-2\7.

Huizinga, T.W.J., Kuijpers, R.W.A.M., Kleijer, M., Schulpen, T.W.J., Cuypers, H.T.M., Roos, D., and von dem Borne, A.E.G.Kr. (1990b). Maternal genomic neutrophil FcRIII deficiency leading to neonatal isoimmune neutropenia. Blood 15:1927-1932.

91

References

Huizinga, T.W.J., de Haas, M., Kleijer, M., Nuijens, J.H., Roos, D., and von dem Borne, A.E.G. Kr. (1990c). Soluble Fey Receptor III in human plasma originates from release by neutrophils. J. Clin. Invest. 86:416-423.

Huizinga, T.W.J., Dolman, K.M., van der Linden, N.J.M., Kleijer, M., Nuijens, J.H., von dem Borne, A.E.G.Kr., and Roos, D. ( 1990d). Phosphatidylinositol-linked FcRIII mediates exocytosis of neutrophil granule proteins, but does not mediate initiation of the respiratory burst. J. Immunol. 144:1432-1437.

Huizinga, T.W.J., Roos, D., and von dem Borne, A.E.G.Kr. (1991). Fc-gamma receptors: mediators, targets and markers of disease. Ballière's Clin. Haematol. 4:889-902.

Huizinga, T.W.J., de Haas, M , van Oers, M.H.J., Kleijer, M, Vilé, H, van der Wouw, P.A., Moulijn, A., van Weezel, H , Roos, D., and von dem Borne, A.E.G.Kr. (1994). The plasma concentration of soluble FcyRHI is related to the production of neutrophils. Br. J. Haematol. 87:459-463.

Huovila, A.-P.J., Almeida, E.A.C., and White, J.M. (1996). ADAMs and cell fusion. Curr. Opin. Cell Biol 8:692-699.

Ierino, F.L., Powell, M.S., McKenzie, I.F.C., and Hogarth, P.M. (1993). Recombinant soluble human FcyRII: production, characterization , and inhibition of the Arthus reaction. J. Exp. Med. 178:1617-1628.

Izumi, Y., Hirata, M., Hasuwa, H , Iwamoto, R, Umata, T., Miyado, K, Tamai, Y., Kurisaki, T., Sehara-Fujisawa, A., Ohno, S., and Mekada, E. (1998). A metalloprotease-disintegrin, MDC9/meltrin-y/ADAM9 and PKC8 are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17:7260-7272.

Jost, C R , Huizinga, T.W.J., de Goede, R., Fransen, J.A.M., Tetteroo, P.A.T., Daha, M.R, and Ginsel, LA. (1990). Intracellular localization and de novo synthesis of FcRIII in human neutrophil granulocytes Blood 75:144-151.

Kahn, J., Ingraham, R.H., Shirley, F., Migaki, I.G, and Kishimoto, T.K. (1994). Membrane proximal cleavage of L-selectin: identification of the cleavage site and a 6-kD transmembrane peptide fragment of L-selectin J Cell Biol. 125:461-470.

Kamiguti, A.S., Zuzel, M., and Theakston, R.D.G. (1998). Snake venom metalloproteinases and disintegrins-interaction with cells. Braz. J. Med. Biol. Res. 31:853-862.

Keller, H.U., and Niggli, V, ( 1993). The PKC-inhibitor Ro 31 -8220 selectively suppresses PMA- and diacylglycerol-induced fluid pinocytosis and actin polymerization in PMNs. Biochem. Biophvs Res Commun 194:1111-1116.

Kent, J.D., Sergeant, S., Burns, D.J., and McPail, L.C. (1996). Identification and regulation of protein kinase C-5 in human neutrophils. J. Immunol 157:4641-4647.

Khayat, D., Soubrane, C, Andrieu, J.M., Visonneau, S., Erne, D., Tourani, J.M., Beldjord, K Weil M Fernandez, E., and Jacquillat, C. (1990). Changes of soluble CD16 levels in serum of HIV-infected patients-correlation with clinical and biological prognostic factors. J. Infect. Dis. 161:430-435.

Kishimoto, T.K., Jutila, M.A., Berg, E.L., and Butcher, E.C. (1989). Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 245:1238-1241.

Kniep, B., and Skubitz, K.M. (1998). Subcellular localization of glycosphingolipids in human neutrophils J Leukoc. Biol. 63:83-88. '

Kobayashi, T , Westerdaal, N.A.C., Miyazaki, A., van der Pol, W.-L., Suzuki, T., Yoshie, H, van de Winkel, J.G.J., and Hara, K. (1997). Relevance of immunoglobulin G Fe receptor polymorphism to recurrence of adult periodontitis in Japanese patients. Infect. Immun. 65:3556-3560.

92

References

Koene H.R., de Haas, M., Roos, D., and von dem Borne, A.E.G.Kr. (1996). NA-phenotype-dependent differences in neutrophil FcyRIIIb expression cause differences in plasma levels of soluble FcyRIII. Br. J. Haematol. 93:235-241.

Koene, H.R., Kleijer, M., Algra, J., Roos, D., von dem Borne, A.E.G.Kr., and de Haas., M. (1997). FcyRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell FcyRIIIa, independently of the FcyRIIIa-48L/R/H phenotype. Blood 90:1109-1114.

Koene, H.R., Kleijer, M., Saak, A.J.G., Sullivan, K.E., Bijl, M., Petri, M.A., Kallenberg, C.G.M., Roos, D., von dem Borne, A.E.G.Kr., and de Haas, M. (1998a). The FcyRIIIA-158F allele is a risk factor for Systemic Lupus Erythematosus. Arthritis Rheum. 41:1813-1818.

Koene, H.R., Kleijer, M, Roos, D., de Haas, M., and von dem Borne, A.E.G.Kr. (1998b). FcyRIIIb gene duplication: evidence for presence and expression of three distinct FcyRIIIB genes in NA(l+,2+)SH(+) individuals. Blood 91:673-679.

Koene, H.R., de Haas, M., Kleijer, M., Huizinga, T.W.J., Roos, D., and von dem Borne, A.E.G.Kr. (1998c). Clinical value of soluble IgG Fe receptor type III in plasma from patients with chronic idiopathic neutropenia. Blood 91:3962-3966.

Krauss, J.C., Poo, H., Xue, W., Mayo-Bond, L., Todd III, R.F., and Petty, H.R. (1994). Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fey receptor Illb and the complement receptor type 3. J. Immunol. 153:1769-1777.

Kuijpers, T.W., Tool, A.T.J., van der Schoot, CE., Ginsei, LA., Onderwater, J.J.M., Roos, D. and Verhoeven, A.J. (1991). Membrane surface antigen expression on neutrophils: a reappraisel of the use of surface markers for neutrophil activation. Blood 78:1105-1111.

Kuijpers, T.W., Hoogerwerf, M., and Roos, D. (1992). Neutrophil migration across monolayers of resting or cytokine-activated endothelial cells. Role of intracellular calcium changes and fusion of specific granules with the plasma membrane. J. Immunol. 148:72-77.

Kurosaki, T., and Ravetch, J.V. (1989). A single amino acid in the glycosyl phosphatidylinositol attachment domain determines the membrane topology of FcyRIII. Nature 342:805-807.

Lantz, M., Bjömberg, F., Olsson, I., and Richter, J. (1994). Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms. J. Immunol. 152:1362-1369.

Letoumeur, O., Kennedy, I.C.S., Brini A.T., Ortaldo, J.R., O'Shea, J.J., and Kinet, J.-P. (1991). Characterization of the family of dimers associated with Fc receptors (FceRI and FcyRIII). J. Immunol. 147:2652-2656.

Levy, P.C., Utell, M.J., Fleit, H.B., Roberts Jr., N.J., Ryan, D.H., and Looney, R.J. (1990). Characterization of human alveolar macrophages Fc receptor III: a transmembrane glycoprotein that is shed under in vitro culture conditions. Am. J. Resp. Cell. Mol. Biol. 5:307-314.

Liles, W.C., Kiener, P.A., Ledbetter, J.A., Aruffo, A., and Klebanoff, S.J. (1996). Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184:429-440.

Löfgren, R., Ng-Sikorski J., Sjölander A., and Andersson, T. (1993). ß2 integrin engagement triggers actin polymerization and phosphatidylinositol triphosphate formation in non-adherent human neutrophils. J. Cell Biol. 123:1597-1605.

Lopez, S., Seveau, S., Lesavre, P., Robinson, M.K., and Halbwachs-Mecarelli, L. (1998). CD43 (sialophorin, leukosialin) shedding is an initial event during neutrophil migration, which could be closely related to spreading of adherent cells. Cell. Adhes. Commun. 5:151-160.

93

References

Luedke, E.S., and Humes, J.L. (1989). Effect of tumor necrosis factor on granule release and LTB4 production in adherent human polymorphonuclear leukocytes. Agent Actions 27:451 -454.

Luna, E.J., and Hitt, A.L. (1992). Cytoskeleton-plasma membrane interactions. Science 258:955-964.

Lunn, CA. , Fan, X., Dalie, B., Miller, K., Zavodny, P.J., Narula, S.K., and Lundell, D. (1997). Purification of ADAM 10 from bovine spleen as a TNFa convertase. FEBS lett. 400:333-335.

Manger, K., Repp, R., Spriewald, B.M., Rascu, A., Geiger, A., Wassmuth, R., Westerdaal, N.A.C., Wentz, B., Manger, B., Kalden, J.R., and van de Winkel, J.G.J. (1998). Fey receptor Ha polymorphism in Caucasian patients with Systemic Lupus Erythematosus. Association with clinical symptoms. Arthritis Rheum. 41:1181-1189.

Manna, S.K., Bhattacharya, C, Gupta, S.K., and Samanta, A.K. (1995). Regulation of interleukin-8 receptor expression in human polymorphonuclear neutrophils. Mol. Immunol. 32:883-893.

Marinetti, G.V., and Cattieu, K. (1982). Composition and metabolism of phospholipids of human leukocytes. Chem. Phys. Lipids 31:169-177.

Maskos, K, Fernandez-Catalan, C , Huber, R, Bourenkov, G.P., Bartunik, H., Ellestad, G.A., Reddy, P., Wolfson, M.F., Rauch, CT., Castner, B.J., Davis, R., Clarke, H.R.G., Petersen, M., Fitzner, J.N., Cerretti, D.P., March, C.J., Paxton, R.J., Black, RA., and Bode, W. (1998). Crystal structure of the catalytic domain of human tumor necrosis factor-a-converting enzyme. Proc. Natl. Acad. Sei. 95:3408-3412.

Masuda, M., and Roos, D. (1993). Association of all three types of FcyR (CD64, CD32, and CD16) with a y-chain homodimer in cultured human monocytes. J. Immunol. 151:7188-7195.

Mathiot, C , Mary, J.Y., Tartour, E., Façon, T., Monconduit, M., Grosbois, B., Pollet, J.P., Michaux, J.L., Euller Ziegler, L, Sautés, C, Bataille, R. and Fridman, W.-H. (1996). Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS). Br. J. Haematol. 95:660-665.

Mathiot, C, Teillaud, J.-L., Elmalek, M., Mosseri, V., Euller-Ziegler, L., Daragon, A., Grosbois, B., Michaux, J.-L., Façon, T., Bernard, J.-F., Duclos, B., Monconduit, M., and Fridman, W.-H. (1993). Correlation between soluble serum CD 16 (sCD16) levels and disease stage in patients with Multiple Myeloma. J. Clin. Immunol. 13:41-48.

Matsuba, K.T., van Eeden, S.F., Bicknell, S.G., Walker, B.A.M., Hayashi, S., and Hogg, J.C., (1997). Apoptosis in circulating PMN: increased susceptibility in L-selectin-deficient PMN. Am. J. Phys. 272:H2852-H2858.

Maxwell, K.F., Powell, M.S., Hulett, M.D., Barton, P.A., McKenzie, I.A.F., Garrett, T.P.J., and Hogarth, P.M. (1999). Crystal structure of the human leucocyte Fc receptor, FcyRIIa. Nat. Struct. Biol. 6:437-442.

Metes, D., Ernst, L.K., Chambers, W.H., Sulica, A., Herberman, R.B., and Morel, P.A. (1998). Expression of functional CD32 molecules on NK cells is determined by an allelic polymorphism of the FcyRIIC gene Blood 91:2369-2380.

Meyer, D., Schiller, C , Westermann, J., Izui, S., Hazenbos, W.L.W., Verbeek, J.S., Schmidt, R.E., and Gessner, J.E. (1998). FcyRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia. Blood 92:3997-4002.

Middelhoven, P.J., Ager, A., Roos, D., and Verhoeven, A.J. (1997). Involvement of a metalloprotease in the shedding of human neutrophil FcyRIIIb. FEBS Lett. 414:14-18.

Middelhoven, P.J., van Buul, J.D., Kleijer, M., Hordijk, P.L., and Roos, D. (1999). Actin polymerization induces FcyRIIIb (CD16) shedding from human neutrophils. Biochem. Biophys. Res. Commun. 255:568-574.

Mitchison, T.J., and Cramer, L.P. (1996). Actin-based cell motility and cell locomotion. Cell 84:371-379.

94

References

Moldovan, I., Galon, J., Maridonneau-Parini, I., Roman-Roman, S., Mathiot, C , Fridman, W.-H., and Sautès-Fridman, C. (1999). Regulation of production of soluble Fey receptors type III in normal and pathological conditions. Immunol. Lett. 68:125-134.

Mollinedo, F., Martin-Martin, B., Gajate, C, and Lazo, P.A. (1998). Physiological activation of human neutrophils down-regulates CD53 cell surface antigen. J. Leukocyt. Biol. 63:699-706.

Moss, M.L., Jin, S.-L.C, Milla, M.E., Bickett, D.M., Bukhart, W., Carter, H.L., Chen, W.-J., Clay, W.C., Didsbury, J.R., Hassler, D., Hoffman, CR., Kost, T.A., Lambert, M.H., Leesnitzer, M.A., McCauley, P., McGeehan, G., Mitchell, J., Moyer, M., Pahel, G., Rocque, W., Overton, L.K., Schoenen, F., Seaton, T., Su, J.-L., Warner, J., Willard, D., and Becherer, J.D. (1997). Cloning of a disfntegrin metalloproteinase that processes precursor tumour-necrosis factor-a. Nature 385:733-736.

Muller Kobold, A.C., Zijlstra J.G., Koene, H.R., de Haas, M., Kallenberg, C.G.M., and Cohen Tervaert, J.W. (1998). Levels of soluble FcyRIII correlate with disease severity in sepsis. Clin. Exp. Immunol. 114:220-227.

Murphy, G, and Crabbe, T. (1995). Gelatinases A and B. Methods Enzymol. 248:470-484.

Murphy, G, and F. Willenbrock. (1995). Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol. 248:496-510.

Nathan, CF. (1987). Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J. Clin. Invest. 80:1550-1560.

Nathan, C, and Sanchez, E. (1990). Tumor necrosis factor and CD11/CD18 (ß2) integrins act synergistically to lower cAMP in human neutrophils. J. Cell. Biol. 111:2171-2181.

Nathan, C , Xie, Q.-W., Halbwachs-Mecarelli, L., Jin, W.W. (1993). Albumin inhibits neutrophil spreading and hydrogen peroxide release by blocking the shedding of CD43 (sialophorin, leukosialin). J. Cell Biol. Yll:2Als-256.

Niessen, H.W.M., and Verhoeven, A.J. (1992). Differential upregulation of specific and azurophilic granule membrane markers in electropermeabilized neutrophils. Cell. Sign. 4:501-509.

Ory, P.A., Clark, M.R., Kwoh, E.E., Clarkson, S.B., and Goldstein, I.M. (1989). Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils. J. Clin. Invest. 84:1688-1691.

Owen, C. A., Campbell, M.A., Sannes, PL., Boukedes, S.S., and Campbell, E.J. (1995). Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteases. J. Cell Biol. 131:775-789.

Paemen, L., Martens, E., Masure, S., and Opdenakker, G. (1995). Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity. Eur. J. Biochem. 234:759-765.

Palecek, S.P., Huttenlocher, A., Horwitz, A.F., and Lauffenburger, DA. (1998). Physical and biochemical regulation of integrin release during rear detachment of migrating cells. J. Cell Sei. 111:929-940.

Parren, P.W.H.I., Warmerdam, P.A.M., Boeije, L.C.M., Arts, J., Westerdaal, N.A.C, Vlug, A., Capel, P.J.A., Aarden, L.A., and van de Winkel, J.G.J. (1992). On the interaction of IgG subclasses with the low affinity FcyRIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J. Clin. Invest. 90:1537-1546.

Pavalko, F.M., and la Roche, S.M. (1993). Activation of human neutrophils induces an interaction between the integrin ß2-subunit (CD18) and the actin binding protein a-actinin. J. Immunol. 151: 3795-3807.

95

References

Pavalko, F.M., Walker, D.M., Graham, L., Goheen, M., Doerschuk, CM., and Kansas, G.S. (1995). The cytoplasmic domain of L-selectin interacts with cytoskeletal proteins via a-actinin: receptor positioning in microvilli does not require interaction with a-actinin. J. Cell Biol. 129:1155-1164.

van Pelt, L.J., van Zwieten, R., Weening, R.S., Roos, D., Verhoeven, A.J., and Bolscher, B.G.J.M. (1996). Limitations on the use of Dihydrorhodamine 123 for flowcytometric analysis of the neutrophil respiratory burst. J. Immunol. Methods 191:187-196.

Peschon, J.J., Slack, J.L., Reddy, P., Stocking, K.L., Sunnarborg, S.W., Lee, D.C., Russell, W.E., Castner, B.J., Johnson, R.S., Fitzner, J.N., Boyce, R.W., Nelson, N., Kozlosky, C.J., Wolfson, M.F., Rauch, CT., Cerretti, D.P., Paxton, R.J., March, C.J., and Black, R.A. (1998). An essential role for ectodomain shedding in mammalian development. Science 282:1281-1284.

Petty, H.R., Kindzelskii, A.L., Adachi, Y., and Todd III, R.F. (1997). Ectodomain interactions of leukocyte integrins and pro-inflammatory GPI-linked membrane proteins. J. Pharma. Biomed. Anal. 15:1405-1416.

Platonov, A.E., Kuijper, E.J., Vershinina, I.V., Shipulin, G.A., Westerdaal, N., Fijen, C.A.P., and van de Winkel, J.G.J. (1998). Meningococcal disease and polymorphism of FcyRIIa (CD32) in late complement component-deficient individuals. Clin. Exp. Immunol. 111:97-101.

Porteu, F., and Nathan, C. (1990). Shedding of tumor necrosis factor receptors by activated human neutrophils. J. Exp. Med. 172:599-607.

del Pozo, M., Pulido, R., Mufioz, C , Alvarez, V., Humbria, A., Camponero, M.R., and Sânchez-Madrid, F. (1994). Regulation of ICAM-3 (CD50) membrane expression on human neutrophils through a proteolytic shedding mechanism. Eur. J. Immunol 24:2586-2594.

del Pozo, MA., Sânchez-Mateos, P., Sânchez-Madrid, F. (1996). Cellular polarization induced by chemokines: a mechanism for leukocyte recruitment? Immunol. Today 3:127-131.

Preece, G., Murphy, G., and Ager, A. (1996). Metalloproteinase-mediated regulation of L-selectin levels on leukocytes. J. Biol. Chem. 271:11634-11640.

Puente, X.S., Pendis, A.M., Llano, E., Velasco, G., and López-Oün, C (1996). Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res. 56:944-949.

Qiu, W.Q., de Bruin, D., Brownstein, B.H., Pearse, R., and Ravetch, J.V. (1990). Organization of the human and mouse low-affinity FcyR genes: duplication and recombination. Science 242: 732-735.

Raknes, G., Skeie, CO., Gilhus, N.E., Aadland, S., and Vedeler, C. (1998). FcyRIIA and FcyRIIIB polymorphisms in Myasthenia Gravis. J. Neuroimmunol 8\:l73-\76.

Rao, N.V., Wehner, N.G., Marshall, B.C., Gray, W.R., Gray, B.H., and Hoidal., J.R. (1991). Characterization of proteinase-3 (Pr-3), a neutrophil serine protease. Structural and functional properties. J. Biol. Chem. 266:9540-9548.

Ravetch, J.V., and Perussia, B. (1989). Alternative membrane forms of FcyRIII (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes which differ in single nucleotide substitutions. J. Exp. Med. 170:481-497.

Remold-O'Donnell, E., and Parent, D. (1995). Specific sensitivity of CD43 to neutrophil elastase. Blood 86:2395-2402.

Renesto, P., Si-Tahar, M., Moniatte, M., Balloy, V., van Dorsselaer, A., Pidard, D., and Chignard, M. (1997). Specific inhibition of thrombin-induced cell activation by the neutrophil proteinase elastase, cathepsin G, and proteinase 3: evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor. Blood 89:1944-1953.

96

References

Reumaux, D., Vossebeld, P.J.M., Roos, D., and Verhoeven, A.J. (1995). Effect of tumor necrosis factor-induced activation on Fc gamma receptor Il-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 86:3189-3195.

Roche: Ro32-7066; range of IC50 against ADAM-family members: 5-20 nM (Roche Research Centre, Welwyn Garden City, Herts., UK).

Roos, D., Voetman, A.A., and Meerhof, L.J. (1983). Functional activity of enucleated human polymorphonuclear leukocytes. J. Cell Biol. 97:368-377.

Roos, D., and de Boer, M. (1986). Purification and cryopreservation of phagocytes from human blood. Methods Enzymol. 132:225-243.

Roos, D., de Boer, M., Kuribayashi, F., Meischl, C, Weening, R.S., Segal, A.W., Âhlin, A., Nemet, K., Hossle, J.P., Bernatowska-Matuszkiewics, E., and Middleton-Price, H. (1996). Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 87:1663-1681.

Ruoslahti, E. (1996). RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 12:697-715.

Sadhukhan, R., Sen, G.C., Ramchandran, R., and Sen, I. (1998). The distal ectodomain of angiotensin-converting enzyme regulates its cleavage-secretion from the cell surface. Proc. Natl. Acad. Sei. 95:138-143.

de la Salle, H., Galon, J., Bausinger, H., Spehner, D., Bohbot, A., Cohen, J., Cazenave, J.-P., Fridman, W.-H., Sautes, C, and Hanau, D. (1997) Soluble CD16/FcyRIII induces maturation of dendritic cells and production of several cytokines including IL-12. In: Dendritic Cells in Fundamental and Clinical Immunology, pp.345-352. Edited by Ricciardi-Castagnoli, Plenum Press, New York.

Salmon, J.E., Edberg, J.C., and Kimberly, R.P. (1990). Fey receptor III on human neutrophils. Allelic variants have functionally distinct capacities. J. Clin. Invest. 85:1287-1295.

Salmon, J.E., Brogle, N.L., Edberg, J.C., and Kimberley, R.P. (1991). Fey receptor III induces actin polymerization in human neutrophils and primes phagocytosis mediated by Fey receptor II. J. Immunol. 146:997-1004.

Salmon, J.E., Ng, S., Sobel, R., Simantov, R., Lo, S.K., Furie, R., Kaell, A., Hamburger, M.I., Silverstein, R., and Sammaritano, L.R. (1997). FcyRIIa allele which binds IgG2 (FcyRIIA-H131) is increased in patients with anticardiolipin antibodies and Thrombosis. Arthritis Rheum. 40:S300.

Sanders, L.A.M, van de Winkel, J.G.J., Rijkers, G.T., Voorhorst-Ogink M.M., de Haas, M., Capel, P.J.A., and Zegers, B.J.M. (1994). Fcy receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J. Infect. Dis. 170:854-861.

Sârmay, G., Rozsnyay, Z., and Gergely, J. (1990). FcyRII expression and release on resting and activated human B lymphocytes. Mol. Immunol. 27:1195-1200.

Sârmay, G., Rozsnyay, Z., Szabó, I., Biro, A., and Gergely, J. (1991). Modulation of type II Fcy receptor expression on activated human B lymphocytes. Eur. J. Immunol. 21: 541-549.

Sautés, C, Teillaud, G, Mazières, N., Tartour, E., Bouchard, G, Galinha, A., Jourde, M., Spagnoli R., and Fridman, W.-H. (1992). Soluble Fcy receptor (sFcyR): detection in biological fluids and production of a murine recombinant sFcyR biologically active in vitro and in vivo. Immunobiology 185:207-221.

Schmid, K., Hediger, M.A., Brossmer, R., Collins, J.H., Haupt, H., Marti, T., Offner, G.D., Schaller, J., Takagaki, K., Walsh, M.T., Schwick, H.G., Rosen, F.S., and Remold-O'Donnell, E. (1992). Amino acid sequence of human plasma galactoglycoprotein: identity with the extracellular region of CD43 (sialophorin). Proc. Natl. Acad. Sei. USA 89:663-667.

97

References

Schneider, P., Holler, N., Bodmer, J.-L., Hahne, M., Frei, K., Fontana, A., and Tschopp, J. (1998). Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187:1205-1213.

Selvaraj, P., Rosse, W.F., Silber R., and Springer, T.A. (1988). The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria. Nature 333:565-567.

Sengelizrv, H , Kjeldsen, L., and Borregaard, N. (1993). Control of exocytosis in early neutrophil activation. J. Immunol. 150:1535-1543.

Sengelcrv, H , Voldstedlund, M., Vinten, J., and Borregaard, N. (1998). Human neutropils are devoid of the integral membrane protein caveolin. J. Leukoc. Biol. 63:563-566.

Sheikh, S., Gratzer, W.B., Pinder, J.C., and Nash, G.B. (1997). Actin polymerisation regulates integrin-mediated adhesion as well as rigidity of neutrophils. Biochem. Biophys. Res. Commun. 238:910-915.

Smyth, L.J.C., Snowden, N., Carthy, D., Papasteriades, C , Hajeer, A., and Ollier, W.E.R. (1997). FcyRIIa polymorphism in Systemic Lupus Erythematosus. Ann. Rheum. Dis. 56:744-746.

Sondermann, P., Huber, R., and Jacob, U. (1999). Crystal structure of the soluble form of the human Fcy-receptor lib: a new member of the immunoglobulin superfamily at 1.7 A resolution. EMBOJ. 18:1095-1103.

Springer, TA. (1994). Traffic Signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76:301-314.

Stein, R.L., and Trainor, DA. (1986). Mechanism of inactivation of human leukocyte elastase by a chloromethyl ketone: kinetic and solvent isotope effects studies. Biochemistry. 25:5414-5419.

Stöckl, J., Majdic, O., Pickl, W.F., Rosenkranz, A., Prager, E., Gschwantler, E., and Knapp, W. (1995). Granulocyte activation via a binding site near the C-terminal region of complement receptor type 3 a-chain (CD1 lb) potentially involved in intramembrane complex formation with glycosylphosphatidylinositol-anchored FcyRIIIb (CD16) molecules. / . Immunol. 154:5452-5463.

Sylvestre D.L., and Ravetch, J.V. (1994). Fc Receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 265:1095-1098.

Takai, T., Li, M., Sylvestre, D., Clynes, R., and Ravetch, J.V. (1994). FcR y chain deletion results in pleiotrophic effector cell defects. Cell 76:519-529.

Tausk, F., Fey, M. and Gigli, I. (1989). Endocytosis and shedding of the decay accelerating factor on human polymorphonuclear cells. J. Immunol. 143:3295-3302.

Taylor, K.B., Windsor, L.J., Caterina, N.C.M., Bodden, M.K., and Engler, J.A. (1996). The mechanism of inhibition of collagenase by TIMP-1. / Biol. Chem. 271:23938-23945.

Teeling, J.L., de Groot, E.R., Eerenberg, A.J.M., Bleeker, W.K., van Mierlo, G, Aarden, L.A., and Hack, CE. (1998). Human intravenous immunoglobulin (IVIG) preparations degranulate human neutrophils in vitro. Clin. Exp. Immunol. 114:264-270.

Teillaud, C, Galon, J., Zilber, M.-T., Mazieres, N., Spagnoli, R., Kurrle, R , Fridman, W.-H, and Sautes, C. (1993). Soluble CD 16 binds peripheral blood mononuclear cells and inhibits pokeweed-mitogen-induced responses. Blood 82:3081-3090.

Teillaud, J.-L., Bouchard, C, Astier, A., Teillaud, C , Tartour, E., Michon, J., Galinha, A., Moncuit, J., Mazières, N., Spagnoli, R., Fridman, W.-H. and Sautés, C. (1994). Natural and recombinant soluble low-affinity FcyR: detection, purification, and funtional activities. Immunomethods. 4:48-64.

98

References

Thompson, H.L., and Matsushima, K. (1992). Human polymorphonuclear leucocytes stimulated by tumour necrosis factor-alpha show increased adherence to extracellular matrix proteins which is mediated via the CD1 lb/CD18 complex. Clin. Exp. Immunol. 90:280-285.

Todd III, R.F., and Petty, H.R. (1997). ß2(CDl 1/CD18) integrins can serve as signaling partners for other leukocyte receptors. J. Lab. Clin. Med. 129:492-498.

Tosi, M.F., and Berger, M. (1988). Functional differences between the 40 kDa and 50 to 70 kDa IgG Fc receptors on human neutrophils revealed by elastase treatment and antireceptor antibodies. / . Immunol 141:2097-2103.

Tosi, M.F., and Zakem, H. (1992). Surface expression of Fey receptor III (CD 16) on chemoattractant-stimulated neutrophils is determined by both surface shedding and translocation from intracellular storage compartments. J. Clin. Invest. 90:462-470.

Tsukita, S., Oishi, K., Sato, N., Sagara, J., Kawai, A., and Tsukita, S. (1994). ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J. Cell Biol. 126:391-401.

Varin, N , Sautés, C , Galinha, A., Even, J., Hogarth, P.M., and Fridman, W.-H. (1989). Recombinant soluble receptor for the Fey portion inhibit antibody production in vitro. Eur. J. Immunol. 19:2263-2268.

Vossebeld, P.J.M., Homburg, C.H.E., Schweizer, R.C., Ibarrola, I., Koenderman, L., Roos, D., and Verhoeven, A.J. (1997). Tyrosine phosphorylation-dependent activation of phosphatidylinoside 3-kinase occurs upstream of Ca2+-signalling induced by Fey receptor cross-linking in human neutrophils. Biochem. J. 323:87-94.

Walcheck, B., Kahn, J., Fisher, J.M., Wang, B.B., Fisk, R.S., Payan, D.G., Feehan, C , Betageri, R., Darlak, K., Spatola, A.F., and Kishimoto, T.K. (1996). Neutrophil rolling altered by inhibition of L-selectin shedding in vitro. Nature 380:720-723.

Walzog, B., Seifert, R., Zakrzewicz A., Gaehtgens P., and Ley, K. (1994). Cross-linking of CD18 in human neutrophils induces an increase of intracellular free Ca2+, exocytosis of azurophilic granules, quantitative up-regulation of CD18, shedding of L-selectin, and actin polymerization. J. Leukoc. Biol. 56:625-635.

Warmerdam, P.A.M., van den Winkel, J.G.J., Gosselin, E.J., and Capel, P.J.A. (1990). Molecular basis for a polymorphism of human Fey receptor II (CD32). J. Exp. Med. 172:19-25.

Werb, Z., and Yan, Y. (1998). A cellular striptease act. Science 282:1279-1280.

Weskamp, G., Krätzschmar, J., Reid, M., and Blobel, C.P. (1996). MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. J. Cell Biol. 132:717-726.

Williams, Y., Lynch, S., McCann, S., Smith, O., Feighery, C, and Whelan, A. (1998). Correlation of platelet FcyRIIA polymorphism in refractory Idiopathic (immune) Thrombocytopenic Purpura. Br. J. Haematol. 101:779-782.

van de Winkel. J.G.J., and Anderson, C.L. (1991). Biology of human immunoglobulin G Fe receptors. J. Leukocyt. Biol. 49:511-524.

van de Winkel, J.G.J., and Capel, P.J.A. (1993). Human IgG Fc receptors heterogeneity: molecular aspects and clinical implications. Immunol. Today 14:215-221.

van de Winkel, J.G.J., de Wit, T.P.M., Ernst, L.K., Capel, P.J.A., and Cueppens, J.L. (1995). Molecular basis for a familial defect in phagocyte expression of IgG receptor I (CD64). J. Immunol. 154:2896-2903.

Wolfsberg, T.G., Straight, P.D., Gerena, R.L., Huovila, A.-P.J., Primakoff, P., Myles, D.G., and White, J.M. (1995a). ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev. Biol. 169:378-383.

99

References

Wolfsberg, T.G., Primakoff, P., Myles, D.G., and White, J.M. (1995b). ADAM, a novel family of membrane proteins containing a disintegrin and rnetalloprotease domain: multipotential functions in cell-cell and cell-matrix functions. J. Cell Biol. 131:275-278.

Wu, J., Edberg, J.C., Redecha, P.B., Bansai, V., Guyre, P.M., Coleman, K., Salmon, J.E., and Kimberly, R.P. (1997). A novel polymorphism of FcyRIIIa (CD 16) alters receptor function and predisposes to autoimmune disease./ Clin. Invest. 100:1059-1070.

Yagami-Hirosama, T., Sato, T., Kurisaki, T., Kamijo, K., Nabeshima, Y., and Fujisawa-Sehara, A. (1995). A metalloproteinase-disintegrin participating in myoblast fusion. Nature 377:652-656.

Yan, S.R., Huang, M., and Berton, G. (1994). Signaling by adhesion in human neutrophils. J. Immunol. 158:1902-1910.

Yan, S.R., Fumagalli, L., and Berton, G. (1996). Activation of SRC family kinases in human neutrophils. Evidence that p58c'fgrand p53/56ly" redistributed to a Triton X-100-insoluble cytoskeletal fraction, also enriched in the caveolar protein caveolin, display an enhanced kinase activity. FEBSlett. 380:198-203.

Yonemura, S., Nagafuchi, A., Sato, N., and Tsukita, S. (1993). Concentration of an integral membrane protein, CD43 (leukosialin, sialophorin), in the cleavage furrow through interaction of its cytoplasmic domain with actin-based cytoskeletons. J. Cell Biol. 120:437-449.

Yoshiyama, K., Higuchi, Y., Kataoka, M., Matsuura, K., and Yamamoto, S. (1997). CD156 (human ADAM8): expression, primary amino acid sequence, and gene location. Genomics 41:56-62.

Zhou, M.-J., Todd III, R.F., van de Winkel, J.G.J., and Petty, H.R. (1993). Cocapping of the leukoadhesin molecules complement receptor type 3 and lymphocyte function-associated antigen-1 with Fey receptor III on human neutrophils. Possible role for lectin-like interactions. J. Immunol. 150:3030-3041.

Zhou, M.-J., and Brown, E.J. (1994). CR3 (Mac-1, aMß2, CDllb/CD18) and FcyRIII cooperate in generation of a neutrophil respiratory burst: requirement for FcyRII and tyrosine phosphorylation. J. Cell Biol. 125:1407-1416.

100